Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase II
TherapeuticsMD, Inc.  (TXMD) Has "Multiple Catalysts" in 2015/16 As Products Develop, Says Cowen and Company 2/25/2015 2:20:14 PM
ISA Pharmaceuticals Announces Start Of First Phase 1/2 Clinical Trial Of Its SLP®-AMPLIVANT® Conjugates 2/26/2015 2:50:22 PM
Afferent Corporation Clinical Data For Lead Candidate, AF-219, Demonstrate Improvements In Pain And Urinary Urgency In Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS) 2/26/2015 10:56:37 AM
Aduro Biotech Collaborates With Leaders In Cancer Research On Investigator-Sponsored Phase 2 Trial Combining Aduro’s Innovative Immunotherapies With Anti-PD-1 Technology To Treat Patients With Advanced Pancreatic Cancer 2/26/2015 10:55:26 AM
Progenics Pharmaceuticals, Inc. (PGNX) Presents Positive Phase 2 Data For PSMA ADC In Metastatic Castration-Resistant Prostate Cancer 2/26/2015 10:15:45 AM
Columbia Laboratories, Inc. (CBRX) To Initiate A Phase 2 Clinical Trial For COL-1077, Lidocaine Bioadhesive 10% Gel, In The Second Quarter Of 2015 2/26/2015 7:01:30 AM
Sangamo BioSciences (SGMO) Presents New Clinical Data At CROI 2015 From Trial Of ZFP Therapeutic Designed To Provide Functional Control Of HIV 2/26/2015 6:42:15 AM
Phosphate Therapeutics Announces Completion Of Subject Recruitment Into The PEACH Pivotal Phase 2 Study Of Its Novel Phosphate Binder (PT20) For The Treatment Of Hyperphosphataemia 2/26/2015 6:38:28 AM
ABIVAX Recruits First Patient In A Pivotal Phase 2b/3 Clinical Trial With ABX203, A Novel Immunotherapy Against Chronic Hepatitis B 2/26/2015 6:36:37 AM
Pfizer (PFE)'s Meningitis B Vaccine Meets Safety, Tolerability Goals in Mid-Stage Study 2/24/2015 11:28:46 AM
Dilafor Announces Positive Results From A Multi Dosing Safety And Pharmacokinetic Clinical Study 2/25/2015 9:52:20 AM
Valeant (VRX) Release: PROVENGE (sipuleucel-T) Demonstrates Sustained Immune Response Two Years After Treatment In Biochemically-Recurrent Prostate Cancer 2/25/2015 7:27:00 AM
MicuRx Pharmaceuticals Initiates U.S. Phase 2 Clinical Trial For Novel Antibiotic MRX-I 2/25/2015 6:44:38 AM
Celldex (CLDX)'s Rindopepimut Deemed a Breakthrough By the FDA 2/23/2015 7:27:38 AM
Teva Pharmaceutical Industries (TEVA) Announces Positive Results For TEV-48125 In Phase IIb Chronic Migraine Study Meeting Primary And Secondary Endpoints 2/24/2015 11:24:10 AM